Evidence into practice. Prescribing selective serotonin reuptake inhibitors
- PMID: 9611911
- DOI: 10.1017/s0266462300012332
Evidence into practice. Prescribing selective serotonin reuptake inhibitors
Abstract
This descriptive analysis examines prescribing trends of antidepressants in English primary care, providing analysis of NHS reimbursement data for groups of antidepressants between 1989 and 1994. Prescribing trends seem unaffected by the release of information on the effectiveness and cost-effectiveness of antidepressant drugs. We found that simple distribution of the results of health technology assessments may not be sufficient to influence practice.
Similar articles
-
Effects of the Committee on Safety of Medicines advice on antidepressant prescribing to children and adolescents in the UK.Drug Saf. 2005;28(12):1151-7. doi: 10.2165/00002018-200528120-00009. Drug Saf. 2005. PMID: 16329717
-
Sociological influences on antidepressant prescribing.Soc Sci Med. 2003 Mar;56(6):1335-44. doi: 10.1016/s0277-9536(02)00132-6. Soc Sci Med. 2003. PMID: 12600369
-
What were the impacts of the Committee on Safety of Medicines warning and publication of the NICE guidelines on trends in child and adolescent antidepressant prescribing in primary care? A population based study.BMJ Open. 2019 Aug 7;9(8):e028201. doi: 10.1136/bmjopen-2018-028201. BMJ Open. 2019. PMID: 31391190 Free PMC article.
-
The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared.J Affect Disord. 2000 Aug;59(2):149-57. doi: 10.1016/s0165-0327(99)00147-0. J Affect Disord. 2000. PMID: 10837883
-
Update on depression and antidepressant medications.Medsurg Nurs. 2006 Aug;15(4):241-6, 222. Medsurg Nurs. 2006. PMID: 16999187 Review. No abstract available.
Cited by
-
Sleeping with the enemy? A randomized controlled trial of a collaborative health authority/industry intervention to influence prescribing practice.Br J Clin Pharmacol. 2000 Feb;49(2):174-9. doi: 10.1046/j.1365-2125.2000.00126.x. Br J Clin Pharmacol. 2000. PMID: 10671913 Free PMC article. Clinical Trial.
-
Do productivity costs matter?: the impact of including productivity costs on the incremental costs of interventions targeted at depressive disorders.Pharmacoeconomics. 2011 Jul;29(7):601-19. doi: 10.2165/11539970-000000000-00000. Pharmacoeconomics. 2011. PMID: 21545189
-
The quantity and quality of clinical practice guidelines for the management of depression in primary care in the UK.Br J Gen Pract. 1999 Mar;49(440):205-10. Br J Gen Pract. 1999. PMID: 10343424 Free PMC article.